Global Health Limited has announced the approval of 10,000 employee stock options (ESOPs) for an employee under its GHL LTIP 2024 Plan. This incentive aims to reward performance and encourage long-term commitment. Each option is exercisable at a price of ₹960 per share, with the scheme designed to foster a sense of co-ownership and wealth creation for the recipient.
Incentive Plan Details
During a meeting held on May 11, 2026, the Nomination and Remuneration Committee of Global Health Limited approved a grant of 10,000 ESOPs to one designated employee. This grant is part of the broader GHL Employees Stock Option Scheme, 2024. The initiative is intended to attract and retain key talent, motivating staff to contribute to the long-term corporate growth and profitability of the company.
Terms and Conditions of the Grant
Key parameters for the options have been established to align with long-term retention goals. Each option grants the right to receive one equity share with a face value of ₹2, at an exercise price of ₹960 per share.
Vesting and Exercise Period
The options are subject to specific vesting schedules outlined in the individual grant letters, with a maximum tenure of 5 years from the date of grant. Once vested, the employee has a window of 3 years to exercise the options from the date of the final vesting installment, ensuring a structured approach to employee wealth creation and long-term incentivization.
Source: BSE
